{"entity":{"type":"insider","cik":"0001615782","url":"/insider/0001615782","json_url":"/insider/0001615782.json","name":"Topspin Fund L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2019-11-15","last":"2020-11-05","span_basis":"filed_date"},"name_variants":[{"name":"Topspin Fund L.P.","source":"filing","n_filings":3,"first_seen":"2019-11-15","last_seen":"2020-11-05"}],"transactions":[{"id":2922531,"accession":"0001104659-20-121613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-121613","line_url":"/filing/0001104659-20-121613#line-1","is_derivative":false,"issuer_cik":"0001200183","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001200183","owner_cik":null,"owner_name":"LG Management, LLC; GUTHART LEO; Topspin Fund L.P.; Topspin Biotech Fund II, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2268750.0,"shares_display":"2,268,750","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":1100446.0,"shares_owned_after_display":"1,100,446","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-05","scope":"insider"},{"id":3212604,"accession":"0001104659-20-067505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-067505","line_url":"/filing/0001104659-20-067505#line-1","is_derivative":false,"issuer_cik":"0001200183","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001200183","owner_cik":null,"owner_name":"LG Management, LLC; GUTHART LEO; Topspin Biotech Fund II, L.P.; Topspin Fund L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2056666.0,"shares_display":"2,056,666","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":559243.0,"shares_owned_after_display":"559,243","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-29","scope":"insider"},{"id":7860855,"accession":"0001104659-19-064691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-064691","line_url":"/filing/0001104659-19-064691#line-1","is_derivative":false,"issuer_cik":"0001200183","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001200183","owner_cik":null,"owner_name":"LG Management, LLC; GUTHART LEO; Topspin Fund L.P.; Topspin Biotech Fund II, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":415000.0,"shares_display":"415,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4980000.0,"total_display":"4,980,000.00","shares_owned_after":2575371.0,"shares_owned_after_display":"2,575,371","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796280","name":"Oric Pharmaceuticals, Inc.","url":"/issuer/0001796280","role":"Ten percent owner","n_filings":1,"first_seen":"2020-11-05","last_seen":"2020-11-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner","n_filings":2,"first_seen":"2019-11-15","last_seen":"2020-05-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001615782","retrieved_at":"2026-08-21T15:49:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}